Axil Capital
Venture capitalTokyo · Seed–Late Stage · 7 people tracked
Investment thesis
Axil Capital pursues a strategy of creating value in the life sciences venture ecosystem by identifying and nurturing transformational biotech and healthcare technologies across the full investment spectrum. The firm diversifies its portfolio across biopharmaceuticals, platform technologies, medical devices, digital health, and healthcare services. The investment thesis emphasizes establishing synergies between Japan's biotech ecosystem and global markets to build commercially viable enterprises with sustainable returns while addressing transformational needs in healthcare and medical innovation.
Source: firm website, verified Aug 5, 2026.
Team · 7 people
from the firm's website & public directories
Frequently asked questions
- What stage does Axil Capital invest at?
- Axil Capital invests at the Seed, Series A, Series B, Series C, Growth, Late Stage stages.
- What sectors does Axil Capital focus on?
- Axil Capital focuses on Biotech, Digital Health, Medical Devices.
- Where is Axil Capital located?
- Axil Capital is headquartered in Tokyo, JP.
Images
Co-investors · 2
Astellas Venture Management (AVM) is the wholly-owned corporate venture arm of Astellas, providing equity investments to private, early-stage biotechnology companies developing therapeutic programs and platform technologies for drug discovery.
Remiges Ventures is a venture capital firm focused on life sciences and drug discovery, backing biotech and therapeutics companies. It launched the RDiscovery Fund to incubate early-stage drug discovery projects.
Firms observed investing alongside Axil Capital, from public investor directories. Shared companies are the overlap with Axil Capital's recorded portfolio.
Similar investors
Amadeus Capital Partners is a technology investment firm that backs founders building complex, science-led and deep tech businesses, supporting them over the long term as they scale internationally.
.jpeg){kind=logo}
B Capital is a global investment firm backing early to late-stage technology innovators across technology, healthcare, and energy & resilience sectors.
Capricorn Partners is a Belgium-based, partner-owned independent management company for alternative investment funds, investing in innovative companies across digital, health and clean technologies with an ESG focus.
DCVC (Data Collective) is a deep tech venture capital firm that backs entrepreneurs using computational approaches to solve large-scale real-world problems across many industries.
GV (Google Ventures) is a venture capital firm that has invested in artificial intelligence and machine learning since its early days, building a global portfolio of more than 100 AI companies across infrastructure, life sciences, and applications.